-+ 0.00%
-+ 0.00%
-+ 0.00%

BLOSSOMHILL THERAPEUTICS - Q3 2026 NET LOSS $24 MLN, OR $1.29 PER SHARE

Reuters·11/12/2026 21:01:01

Please log in to view news